Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when MBOT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: MBOT Microbot Medical Inc. 8-K

Microbot Medical secures first Midwest healthcare system customer in Michigan

Filed June 9, 2026 · Period ending June 9, 2026 · ~1 min read

2 key changes 2 sections

Key Changes

  • medium

    Company announced its first customer account in the Midwest region, a healthcare system in Michigan, marking geographic expansion into a new U.S. market.

  • low

    Disclosure made under Regulation FD (Item 7.01), indicating voluntary release of material information to ensure fair public dissemination.

Summary

Microbot Medical announced it has secured its first customer in the Midwest, a healthcare system based in Michigan. This represents a geographic expansion for the medical device company, which has been working to build its commercial footprint across U.S. regions. The disclosure was made under Regulation FD rules, which companies use to voluntarily share material information with all investors simultaneously.

For retail shareholders, this signals progress in the company's sales efforts and validates its technology in a new market region. Healthcare system accounts can be significant because they often involve multiple facilities and may lead to broader adoption. Investors should watch for follow-on announcements about the size of this contract, implementation timelines, and whether the Michigan win helps open doors to other Midwest healthcare systems.

Section-by-Section Diff

Event · Item 7.01 — Regulation FD Disclosure

~14 words

Regulation FD disclosure filing with incomplete content provided for analysis.

1 Added
Show 1 minor / wording change
Added Regulation FD Disclosure low

Added in current filing · verify on EDGAR →

Item 7.01 Regulation FD Disclosure. The information contained below in

The filing indicates a Regulation FD disclosure under Item 7.01, which typically involves voluntary disclosure of material non-public information to ensure fair dissemination. However, the provided text is incomplete and does not contain the actual disclosure content, making it impossible to assess the materiality or nature of the information being disclosed.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

Microbot Medical filed an 8-K attaching a press release; no material business event disclosed in the filing body.

1 Added
Show 1 minor / wording change
Added Press release attachment low

Added in current filing · verify on EDGAR →

Item 9.01. Financial Statements and Exhibits. (d) Exhibits | Exhibit | Number | Description | 99.1 | Press Release

The 8-K discloses only that a press release is attached as Exhibit 99.1. The filing body provides no details about the content or subject matter of the press release, making it impossible to assess materiality from this document alone.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 10, 2026 · How we verify